Novocure™ has a new FDA-approved weapon (NovoTTF-100A System™) for patients and physicians in the battle against cancer (specifically for treating recurrent brain tumors). Microcurrent therapy is a novel anti-mitotic treatment that has been shown to slow or reverse tumor progression by inducing cell death in certain solid tumors. Their microcurrent device will be available for prescription use in the U.S. initially through several noted brain cancer research centers.

Pulsed electromagnetic field (PEMF) therapy has been used to treat almost every conceivable human illness or malady, including many inflammatory diseases such as arthritis or psoriasis and you don’t have to wait for the FDA to approve this treatment for your kind of cancer. All you have to do is choose among the many options in terms of equipment.

Pulsed electromagnetic field therapy (PEMFT), also called pulsed magnetic therapy, pulse magnetotherapy, or PEMF, is a reparative technique most commonly used in the field of orthopedics for the treatment of non-union fractures, failed fusions, congenital pseudarthrosis and depression. In the case of bone healing, PEMF uses electrical energy to direct a series of magnetic pulses through injured tissue whereby each magnetic pulse induces a tiny electrical signal that stimulates cellular repair.

Many studies have also demonstrated the effectiveness of PEMF in healing soft-tissue wounds, suppressing inflammatory responses at the cell membrane level to alleviate pain and increase range of motion. The value of pulsed electromagnetic field therapy has been shown to cover a wide range of conditions, with well-documented trials carried out by hospitals, rheumatologists, physiotherapists and neurologists. In years past this has been a very expensive form of therapy using sophisticated equipment, but that has all changed.

For more, see: